Mary Thistle serves as Executive at ZIOPHARM ONCOLOGY INC, where they oversee executive responsibilities. Since joining the company, Mary Thistle has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 5, 2025 involved selling 5,000 shares valued at $0.
Mary Thistle currently holds 45,000 shares of ZIOPHARM ONCOLOGY INC (ZIOP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mary Thistle has been a net neutral trader of ZIOP stock. They have purchased $0 and sold $0 worth of shares.
Mary Thistle's most recent insider trade was on Aug 5, 2025, when they sold 5,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 22, 2022 | TCRT | $0 | Award | 40,000 | $N/A | Discretionary |
| Mar 4, 2021 | ZIOP | $0 | Award | 5,000 | $N/A | Discretionary |